DKCM
OPTR

Davidson Kempner Capital Management’s OPTIMER PHARMACEUTICALS, INC. COM STK OPTR Stock Holding History

Davidson Kempner Capital Management’s Portfolio OPTR Stock Details OPTR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2013
Q4 		– Sell
-1,845,022
Closed -$23.2M – 191
2013
Q3 		$23.2M Buy
+1,845,022
New +$24.4M 0.77% 25

Davidson Kempner Capital Management's OPTR Position: Q4 2013 in Review

Davidson Kempner Capital Management sold out of OPTIMER PHARMACEUTICALS, INC. COM STK (OPTR) in Q4 2013, closing a stake of 1,845,022 shares — an estimated $23.2M sold.

Davidson Kempner Capital Management first reported a position in OPTR in Q3 2013 and held it in 1 quarter. The position peaked at $23.2M in Q3 2013. 0 funds tracked by Wall St. Rank hold OPTR as of Q4 2013.

  • Davidson Kempner Capital Management reported no remaining OPTIMER PHARMACEUTICALS, INC. COM STK position as of Q4 2013 after selling out during the quarter.
  • Davidson Kempner Capital Management sold 1,845,022 OPTIMER PHARMACEUTICALS, INC. COM STK shares in Q4 2013, an estimated $23.2M.
  • Davidson Kempner Capital Management first reported a position in OPTIMER PHARMACEUTICALS, INC. COM STK in Q3 2013 and held it in 1 quarter.
  • Davidson Kempner Capital Management's OPTIMER PHARMACEUTICALS, INC. COM STK position peaked at $23.2M in Q3 2013.
  • 0 funds tracked by Wall St. Rank held OPTIMER PHARMACEUTICALS, INC. COM STK as of Q4 2013.

Based on Davidson Kempner Capital Management's 13F filing for Q4 2013, filed 14 Feb 2014.